1812
I. M. Kalinowska et al.
PAPER
(Fur)3P (4.6 mg, 0.02 mmol), [Ru(p-cymene)Cl2]2 (6.1 mg, 0.01
mmol) and the acetylene (2.1 mmol) in anhyd toluene (2 mL) was
added. The mixture was heated at 65 °C until TLC indicated com-
plete conversion of the amino acid derivative. The solvent was
evaporated and the residue dissolved in CHCl3 (10 mL). The organ-
ic layer was washed with sat. aq NaHCO3 soln (3 × 4 mL) and dried
over anhyd MgSO4. The solvent was removed and the product pu-
rified by column chromatography over silica gel (eluent: hexane–i-
PrOH).
MS (ESI+): m/z (%) = 445.2 (100) [M + Na]+, 867.4 (20) [2M +
Na]+.
(S)-(+)-Hexan-2-ol
Compound 6a (0.046 g, 0.11 mmol) was added to a mixture of H2O
(2 mL), EtOH (2 mL) and KOH (0.4 g). The resulting mixture was
heated at reflux temperature until ester 6a had been consumed
(TLC) and was then extracted with CHCl3 (2 × 1 mL). The com-
bined organic phase was dried over anhyd MgSO4 and evaporated
to afford (S)-(+)-hexan-2-ol.
Hex-1-en-2-yl N-Carbobenzyloxytryptophanate (1)
Yellow solid; yield: 1.33 g (99%); mp 58–61 °C; [a]D +11.6 (c
1.08, CHCl3).
Colorless liquid; yield: 6 mg (54%); ee >98%; [a]D25 +11.8 (c 0.56,
25
CHCl3) {Lit.21 [a]D +12.0 (c 0.2, CHCl3)}. All other analytical
25
data were consistent with those reported in the literature.21
1H NMR (500 MHz, CDCl3): d = 8.11 (br s, 1 H), 7.58 (d, J = 7.8
Hz, 1 H), 7.37–7.28 (m, 5 H), 7.19 (t, J = 7.1 Hz, 1 H), 7.10 (t,
J = 7.5 Hz, 1 H), 7.00–6.99 (m, 1 H), 5.33 (d, J = 8.3 Hz, 1 H), 5.12
(d, J = 12.5 Hz, 1 H), 5.08 (d, J = 12.5 Hz, 1 H), 4.80–4.77 (m, 1 H),
4.68 (br s, 1 H), 4.60 (br s, 1 H), 3.39–3.31 (m, 2 H), 2.09–2.04 (m,
2 H), 1.62 (s, 1 H), 1.37–1.25 (m, 4 H), 0.86 (t, J = 7.3 Hz, 3 H).
13C NMR (125 MHz, CDCl3): d = 170.3, 156.4, 155.7, 136.3, 136.1,
128.5, 128.2, 128.1, 127.6, 122.8, 122.3, 119.8, 118.8, 111.2, 109.8,
101.3, 66.9, 54.7, 32.8, 28.4, 27.9, 22.0, 13.8.
2-Oxo-2-phenylethyl (2S)-2-(1,3-Dioxo-1,3-dihydro-2H-isoin-
dol-2-yl)propanoate (7)
Enol ester 3 (0.4 g, 1.3 mmol) was dissolved in CHCl3 (2 mL) and
added dropwise to a soln of MCPBA (0.210 g, 2.6 mmol) in CHCl3
(8 mL) at 0 °C. The mixture was stirred at r.t. for 3 d. The organic
layer was washed with 10% aq NaHCO3 soln (3 × 4 mL), dried over
MgSO4 and evaporated. The residue was purified by column chro-
matography on silica gel (hexane–i-PrOH, 20:1).
White solid; yield: 0.24 g (55%); mp 133–135 °C; [a]D25 +26.4 (c
1.0, CHCl3).
1H NMR (500 MHz, CDCl3): d = 7.89–7.85 (m, 4 H), 7.76–7.72 (m,
2 H), 7.57 (t, J = 7.6 Hz, 1 H), 7.46 (t, J = 7.8 Hz, 2 H), 5.44 (d,
J = 16.5 Hz, 1 H), 5.33 (d, J = 16.5 Hz, 1 H), 5.21 (q, J = 7.3 Hz, 1
H), 1.79 (d, J = 7.3 Hz, 3 H).
MS (ESI+): m/z (%) = 443.2 (100) [M + Na]+, 863.4 (15) [2M +
Na]+.
1,4-Dimethoxybut-2-en-2-yl (2S)-2-(1,3-Dioxo-1,3-dihydro-2H-
isoindol-2-yl)propanoate (4)
Yellow oil; yield: 1.15 g (69%); [a]D25 –14.0 (c 1.05, CHCl3).
1H NMR (200 MHz, CDCl3): d = 7.91–7.83 (m, 2 H), 7.79–7.72 (m,
2 H), 5.59 (t, J = 7.3 Hz, 1 H), 5.09 (q, J = 7.1 Hz, 1 H), 4.14–3.92
(m, 4 H), 3.33 (s, 3 H), 3.29 (s, 3 H), 1.72 (d, J = 7.1 Hz, 3 H).
13C NMR (50 MHz, CDCl3): d = 168.5, 167.4, 148.0, 134.4, 132.1,
123.2, 119.6, 67.7, 66.7, 58.4, 58.1, 47.5, 15.5.
13C NMR (125 MHz, CDCl3): d = 191.3, 169.3, 167.3, 134.2, 134.1,
133.9, 132.0, 128.9, 127.8, 123.6, 66.9, 47.5, 15.3.
MS (ESI+): m/z (%) = 360.1 (100) [M + Na]+.
(2R)-1,4-Dimethoxy-3-oxobutan-2-yl (2S)-2-(1,3-Dioxo-1,3-di-
hydro-2H-isoindol-2-yl)propanoate (8a) and (2S)-1,4-
Dimethoxy-3-oxobutan-2-yl (2S)-2-(1,3-Dioxo-1,3-dihydro-2H-
isoindol-2-yl)propanoate (8b)
MS (ESI+): m/z (%) = 356.1 (100) [M + Na]+, 372.1 (10) [M + K]+,
689.2 (27) [2M + Na]+.
Enol ester 4 (0.3 g, 0.92 mmol) was dissolved in CHCl3 (8 mL) and
added dropwise to a soln of MCPBA (0.32 g, 1.9 mmol) in CHCl3
(2 mL) at 0 °C. The mixture was stirred at r.t. for 5 d. The organic
layer was washed with 10% aq NaHCO3 soln (3 × 4 mL) and dried
over MgSO4. Residual MCPBA was removed by column chroma-
tography over basic Al2O3 (eluent: CHCl3). The solvent was evapo-
rated and the residue subjected to column chromatography over
silica gel (eluent: hexane–Et2O, 1:1) to afford a-acyloxy ketones 8a
and 8b as a 5:3 mixture of diastereomers in 60% combined yield.
Hydrogenation of Enol Esters 1–5; General Procedure
The enol ester (0.71 mmol) was dissolved in i-PrOH (or AcOH) (6
mL) and PtO2 (16.2 mg, 0.071 mmol) was suspended in the mixture.
The suspension was stirred under H2 for 20 h (or 5 h) at r.t. The cat-
alyst was removed by filtration and the solvent evaporated. The res-
idue was dissolved in CHCl3 (6 mL), washed with a small amount
of sat. aq NaHCO3 soln (2 mL) and dried over anhyd MgSO4. The
solvent was evaporated and the residue purified by silica gel column
chromatography (eluent: hexane–i-PrOH).
White solid; yield: 0.19 g (60%); mp 121–129 °C.
(1S)-1-Methylpentyl N-Carbobenzyloxy-l-tryptophanate (6a);
Table 2, Entry 3
Compound 1 (0.4 g, 0.95 mmol) was dissolved in AcOH (6 mL) and
PtO2 (21.6 mg, 0.095 mmol) was suspended in the mixture. The
mixture was stirred under H2 for 5 h at r.t. Product 6a was purified
by silica gel column chromatography (eluent: hexane–i-PrOH, 9:1)
and subsequently recrystallized from Et2O–hexane.
1H NMR (500 MHz, CDCl3): d (major component, 8a) = 7.89–7.87
(m, 2 H), 7.76–7.75 (m, 2 H), 5.44 (dd, J1 = 4.9, J2 = 3.4 Hz, 1 H),
5.13 (q, J = 7.3 Hz, 1 H), 4.15 (d, J = 18.0 Hz, 1 H), 4.09 (d,
J = 18.0 Hz, 1 H), 3.87 (dd, J1 = 10.8, J2 = 4.9 Hz, 1 H), 3.70 (dd,
J1 = 10.8, J2 = 3.4 Hz, 1 H), 3.35 (s, 3 H), 3.32 (s, 3 H), 1.77 (d,
J = 7.3 Hz, 3 H).
1H NMR (500 MHz, CDCl3): d (minor component, 8b) = 7.87–7.86
(m, 2 H), 7.75–7.73 (m, 2 H), 5.40 (dd, J1 = 4.9, J2 = 2.8 Hz, 1 H),
5.11 (q, J = 7.3 Hz, 1 H), 4.22 (d, J = 17.5 Hz, 1 H), 4.19 (d,
J = 17.5 Hz, 1 H), 3.83 (dd, J1 = 11.3, J2 = 4.3 Hz, 1 H), 3.60 (dd,
J1 = 10.7, J2 = 3.5 Hz, 1 H), 3.42 (s, 3 H), 3.22 (s, 3 H), 1.76 (d,
J = 7.3 Hz, 3 H).
White solid; yield: 0.257 g (64%); mp 104–106 °C; [a]D25 +16.0 (c
1.13, CHCl3).
1H NMR (500 MHz, CDCl3): d = 8.04 (br s, 1 H), 7.56 (d, J = 8.3
Hz, 1 H), 7.37–7.27 (m, 6 H), 7.19–7.16 (m, 1 H), 7.10–7.06 (m, 1
H), 5.32–5.28 (m, 1 H), 5.13–5.05 (m, 2 H), 4.89–4.83 (m, 1 H),
4.70–4.67 (m, 1 H), 3.34–3.23 (m, 2 H), 1.60–1.58 (m, 1 H), 1.54–
1.46 (m, 2 H), 1.43–1.36 (m, 1 H), 1.24–1.23 (m, 3 H), 1.14–1.10
(m, 3 H), 0.89–0.83 (m, 3 H).
13C NMR (125 MHz, CDCl3): d = 171.7, 155.8, 136.4, 136.1, 128.5,
128.2, 122.7, 122.3, 119.7, 118.9, 111.1, 110.2, 72.7, 66.9, 65.7,
54.7, 35.4, 31.7, 27.3, 22.4, 19.7, 13.9.
13C NMR (125 MHz, CDCl3): d (diastereomeric mixture) = 202.4,
202.2, 169.1, 167.3, 167.2, 134.3, 134.2, 131.8, 123.6, 123.5, 77.6,
76.3, 76.2, 77.1, 71.0, 59.5, 59.4, 59.2, 47.5, 47.4, 15.2.
MS (ESI+): m/z (%) = 372.0 (100) [M + Na]+, 388.0 (3) [M + K]+,
721.1 (6) [2M + Na]+.
Synthesis 2011, No. 11, 1809–1813 © Thieme Stuttgart · New York